Regulations and compliance · Practical guide

eConsent: linking the evidence of consent to the version the participant saw

Which information did a participant see, who consented and what could the person retain? For eConsent, link the decision to the information and version available at the time. Trial sites, sponsors and IT can then manage version changes while preserving the history of consent.

Table of contents

At a glance

How do you show which version of the information a participant consented to?

Link consent to the approved information package actually used, the identities involved and the documented time. Retain supporting materials, relevant history and the copy provided to the participant. Control version changes so superseded information cannot be used unnoticed. Assess separately whether new information calls for reconsent. Applicable national requirements still govern.

  • Consent encompasses more than just the electronic signature field.
  • Videos and linked information may also constitute the relevant version status.
  • New information requires a justified decision regarding communication and renewed consent.

eConsent includes information, exchange, and decision-making

An electronic signature process is only part of the consent process. The EMA defines eConsent as the combination of information, opportunity for exchange, and documented consent. Paper, electronic, and hybrid approaches shall be evaluated within the respective national legal framework; the presence of an app feature does not determine the legal or ethical acceptability.

Sources: [1] [2]

Which version was actually shown to the individual?

Compile the approved materials, their provision, and the specific consent. The information package may include, in addition to the main document, videos, linked explanations, and language-specific versions. Therefore, the release of a PDF file does not confirm that the additional information available during actual execution was accessible.

Distinguish the most recent available version from the version released for a specific location and time point. A technical version comparison shall not implicitly substitute for the decision of the responsible ethics committee. The matrix below is a standalone reference tool for the required assignment.

Link their specific consent to their current information status
Item requiring evidenceReference requiredTypical gap
Approved Information Package Version, language and responsible authorization Only main PDF recorded; additional video unknown.
Provision Appropriate location, personnel context, and timing The global latest version supersedes the unverified local version.
Discussion and Questions Intended exchange and parties involved Signature click is erroneously considered evidence of a complete process.
Consent Identity, date, and actually used information status Signature is only linked to the current, subsequently replaced document.
Participant copy Signed version with associated information Download leads exclusively to the new version after update.

Sources: [1] [2]

Identity and time reference must align with the procedure.

Verify how the identity of the signing individual and, if applicable, the legal representative is established. The individual conducting the consent discussion is also part of the controlled process. The EMA outlines specific requirements for electronic signatures and time stamps; therefore, there is no blanket obligation to use a particular commercially available signature class across all jurisdictions.

A remote procedure requires an appropriate pathway for questions and clear, understandable responses. It must be legally permissible within the national framework and adequately considered by the relevant ethics committee. An automatically generated link alone does not establish identity or provide sufficient information. Evaluate the technology and actual workflow jointly.

Sources: [1] [2]

Example: A new version coincides with an ongoing discussion

Example: Site A is using an approved information package version V2, including a form, explanatory video, and participant copy. A person begins the intended process on Monday. On Tuesday, version V3 is released for this site. At this point, the individual has not yet provided consent. The team had previously determined that V3 will be used for new consents upon activation.

The test verifies whether the already opened link inadvertently permits a stale consent. Additionally, it checks whether a valid V2 consent documented prior to the transition remains accessible via V2. New information may necessitate a renewed consent; whether such a renewal is required in a specific case will be assessed separately.

Decision points for version upgrades in the example
CasePreliminary defined ruleExpected evidence
V2-Link open, no consent granted yet Upon activation, V3 will be used for new consents. Prevent obsolete closures; personnel receives V3 and appropriate replacement.
V2-Consent already completed Do not replace historical information afterwards. Signature, V2 materials, and the original participant copy remain associated.
V3 includes new relevant information Assess the effect on willingness to participate and the need for renewed consent separately. Assessment, required communication, and, if applicable, new consent to be documented.
V3-formular, but video still V2 The information package must correspond to the approved scope. Identify deviations; clarify release of the complete package prior to further use.

Sources: [1] [2]

Not every update implies the same impact.

ICH E6(R3) requires timely communication of new knowledge that may be relevant to an organization's continued participation. Whether renewed consent is required should be assessed. A blanket rule that "each version number requires re-consent" is equally inadequate, as is the assumption that "once signed, consent is always valid."

Document what changed and its significance. Is it a presentational change, or does it alter information relevant to a decision? Identify affected approved materials and how trial participants and sites will be informed. Obtain the necessary approval before using new or revised materials in the process.

Sources: [2] [1]

The participant copy must not be lost during updates

The EMA provides that participants can immediately receive a copy of the signed consent including accompanying or linked information, either electronically or on paper. Therefore, not only plan the closing screen. Check what a new download will actually deliver after a version change or after the end of the access.

Retain the materials provided and evidence of the consent process. Where copies replace originals, apply the requirements for suitable certified copies. The trial site must retain the intended access and control. A central platform alone gives the sponsor no need to see all identifying information.

Sources: [1] [2]

Further reading:

Hybrid approaches and considering recall scenarios

When a combination of electronic information and paper signature is used, the linkage between the two components must be traceable. The signed paper portion must not be archived independently of the actually utilized information system. Similarly, a person who is unable to effectively use the digital process must have a predefined alternative pathway.

An electronic withdrawal must reach the responsible trial site under the defined procedure. Distinguish further participation, future data collection and handling of data already lawfully obtained. A general delete button cannot resolve all three. Applicable requirements and trial procedures determine the consequences.

Sources: [1]

Checklist for eConsent Version Traceability

Test the process from both the participant's and trial site's perspectives. A successful signature test covers only part of it. Include an open consent process during a version change and later retrieval of an earlier consent.

  • Approved information package including supplemental materials is identified.
  • Appropriate housing, language, location, and activation time are assigned.
  • Identity, replacement, and signature are appropriately designed.
  • Old versions cannot be used unnoticed for new consents.
  • Historical consents remain associated with their original information context.
  • New information will be evaluated regarding communication and renewed consent.
  • User copies and inspection site access remain functional after a version change.
  • Hybrid approaches, alternative pathways, and withdrawal options are considered in the procedure.

Sources: [1] [2]

Project experience and collaboration

Trace the consent version change at the study site

With study owners and the system team, we test a change to approved participant information. Which version applied at each site and time, and what happens to a consent process already underway? A controlled platform configuration may allow focused tests of activation and withdrawal. Multiple languages or site-specific approvals need additional checks of their relationships. Each consent must remain linked to its records. The current document does not establish what the participant received at the time.

Frequently asked questions about eConsent version traceability

Does an electronic signature constitute valid eConsent?

It covers only part of the procedure. Information, opportunity for questions, identity, appropriate authorizations, and documented decision must be consistent. National legitimacy must also be verified. A successful signature process does not substitute for these substantive and procedural prerequisites.

Sources: [1] [2]

Which version must remain linked with the consent?

The actually used, for the specific process appropriate approved information status. This may include supplementary media and linked information. A historical consent must not be redirected solely to the latest file if this renders the original basis no longer discernible.

Sources: [1]

Must approval be re-obtained after each version change?

Not automatically. E6(R3) requires an assessment to determine whether new information affects the participant's willingness to continue and whether a renewed consent is necessary. Document the significance and the decision. Simply assigning a new file number does no more to answer this question than a general trivialization of all changes.

Sources: [2]

Can an already opened link close the previous version?

As a new version for a site becomes effectively activated, the continued use of outdated versions must be prevented according to the approved procedure. The EMA Guideline outlines this control in A5.3.8. Therefore, review any ongoing, yet not yet completed processes and document how they are correctly resumed or restarted.

Sources: [1]

Is a qualified electronic signature always required?

The GCP guidelines referenced here do not establish a general obligation to use a specific signature class for each country and each procedure. Review the national legal framework, requirements of the relevant ethics committee, and reliable identity and signature implementation. A product designation does not substitute for this evaluation.

Sources: [1] [2]

Can electronic information and a paper signature be used?

A hybrid approach is acknowledged in the EMA guidelines. It requires a verifiable linkage between a paper signature and the electronically provided information. Additionally, verify the relevant authorizations and intended workflow; a standalone signature page is insufficient as a version proof.

Sources: [1]

What must the individual be able to obtain as a copy?

The signed consent together with the accompanying or linked information in the prescribed procedure. The EMA refers to electronic or physical availability. Assess practical retrievability and completeness, particularly if content is updated or access is terminated later.

Sources: [1] [2]

Can the Sponsor view all identifiable consent data?

Not automatically. The sponsor may need information about consent status and the applicable version without unrestricted access to identifying documents. The EMA emphasises trial site control and confidentiality. Set permissions according to the actual task and framework.

Sources: [1]

How do we handle a replaced video with unchanged form?

Consider the complete information package. If an accompanying medium is updated, the actual information presented may differ from the original, despite unchanged form number. Evaluate content, authorization, and version assignment before implementing the modified package.

Sources: [1]

Does an electronic withdrawal automatically delete prior data?

No. The withdrawal must reach the responsible trial site, and its consequences follow applicable requirements and trial procedures. Continued participation, future collection and data already lawfully obtained are separate questions.

Sources: [1]

Sources and review date

Sources checked on 7 October 2026. ICH E6(R3) Principles and Annex 1 have applied in the EU since 23 July 2025. The final Annex 2 has been published, with an EU effective date of 15 January 2027. The 2023 EMA computerised systems guideline explains GCP expectations and is not an EU regulation. This article covers clinical trials of human medicines. The examples are our working materials. Applicable regional law and trial documents remain decisive.

  1. EMA: Computerised systems and electronic data in clinical trialsFinal Guideline of 9 March 2023. Annex 5: Introduction to A5.3 and A5.3.1–A5.3.10 on the electronic consent process.
  2. EMA/ICH: E6(R3), Principles and Annex 1, Step 5Principles and Annex 1 (Step 5), EU-effective from 23 July 2025. Sections 2.8.1–2.8.11 relating to consent.
  3. EMA: ICH E6 Good Clinical Practice – current versionStatus page, accessed on 7 October 2026. Principles and Annex 1: EU-effective from 23 July 2025; Annex 2: EU-effective from 15 January 2027.

Sources checked: .

Daniel Herrmann, Daniel Herrmann Consulting

Daniel Herrmann Consulting

eConsent workflows are professionally and technically binding.

We support you with versioning rules, access decisions, and conclusive validation assessments for your electronic consent process.

  • Computer system validation →

    Bring your GxP systems into validated operation, from laboratory software, MES and eQMS to ERP. We define the scope, plan risk-based tests using GAMP 5 and hand the evidence to QA for release.

Send a project enquiry Customer testimonials →